Search - tctmd.com

Displaying 61 - 74 of 74

Sort: Relevancy | Date

Presentation THT Abstracts 2024

Interim Results from Adaptive Randomized Controlled Trial of Autologous Bone Marrow Mononuclear Cells Using the CardiAMP Cell Therapy System in Patients with Ischemic Heart Failure due to Reduced Left Ventricular Ejection Fraction (HFrEF)

Presenter: Amish Raval

March 04, 2024

Presentation THT Abstracts 2024

Vsling- Ventricular repair device for HFrEF patients

Presenter: Boaz Manash

March 04, 2024

Presentation THT Abstracts 2024

First in Man CardiALLO NK1R+ MSC Phase I/II Trial in Ischemic NYHA II and III HFrEF

Presenter: Carl Pepine

March 04, 2024

Presentation THT Abstracts 2024

Effect Of Vagal Nerve Stimulation On Quality Of Life, Functional Capacity, And Left Ventricular Function In Patients With Chronic Heart Failure: An Update On The ANTHEM-HFrEF Pivotal Study Results

Presenter: Marvin Konstam

March 04, 2024

Presentation THT 2024

When to consider AccuCinch

Presenter: Sean P. Pinney

March 04, 2024

Presentation THT 2024

Transcatether Left Ventricular Restoration (TLVR): The AccuCinch Approach

Presenter: Ulrich P. Jorde

March 04, 2024

Presentation THT 2024

Why Treat The Dilated Left Ventricle

Presenter: Daniel Burkhoff

March 04, 2024

Presentation THT 2024

FDA-Approved But Less Frequently Used Device Therapies to Treat HFrEF: Challenges and Opportunities

Presenter: Michael R. Zile

March 04, 2024

News Opinion CV Team Dispatch

March 2024 Dispatch for the CV Team

L.A. McKeown

March 01, 2024

News Daily News

More Mortality Reduction Signals With Implantable Hemodynamic Monitors in HFrEF: Meta-analysis

L.A. McKeown

February 12, 2024

News Daily News

GDMT Rates Low in HFrEF, Particularly in Women

L.A. McKeown

January 30, 2024

News Opinion CV Team Dispatch

January 2024 Dispatch for the CV Team

L.A. McKeown

January 01, 2024

Video

» Topical Discussion

Quick Takes: Amin Yehya on the Use of ICD Therapy for HFrEF Patients

December 17, 2024

Video

» Topical Discussion

Quick Takes: Amole Ojo on Risks of Digoxin Use in HFrEF Patients

July 8, 2024

Advertisement

Interim Results from Adaptive Randomized Controlled Trial of Autologous Bone Marrow Mononuclear Cells Using the CardiAMP Cell Therapy System in Patients with Ischemic Heart Failure due to Reduced Left Ventricular Ejection Fraction (HFrEF)

Vsling- Ventricular repair device for HFrEF patients

First in Man CardiALLO NK1R+ MSC Phase I/II Trial in Ischemic NYHA II and III HFrEF

Effect Of Vagal Nerve Stimulation On Quality Of Life, Functional Capacity, And Left Ventricular Function In Patients With Chronic Heart Failure: An Update On The ANTHEM-HFrEF Pivotal Study Results

When to consider AccuCinch

Transcatether Left Ventricular Restoration (TLVR): The AccuCinch Approach

Why Treat The Dilated Left Ventricle

FDA-Approved But Less Frequently Used Device Therapies to Treat HFrEF: Challenges and Opportunities

March 2024 Dispatch for the CV Team

More Mortality Reduction Signals With Implantable Hemodynamic Monitors in HFrEF: Meta-analysis

GDMT Rates Low in HFrEF, Particularly in Women

January 2024 Dispatch for the CV Team

Quick Takes: Amin Yehya on the Use of ICD Therapy for HFrEF Patients

Quick Takes: Amole Ojo on Risks of Digoxin Use in HFrEF Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content